Colin Waltz

Mr. Colin Waltz

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 May 2024 in Parkinsonism & Related Disorders
Verified
Journal Article
Open access
ARAnson Rosenfeldt
Anson Rosenfeldt
CWColin Waltz
Colin Waltz
EZEric Zimmerman
Eric Zimmerman
SDSara Davidson
Sara Davidson
KHKarissa Hastilow
Karissa Hastilow
JAJay Lance Alberts
Jay Lance Alberts

Verified
Journal Article
Open access
PDF file
ABAndrew Bazyk
Andrew Bazyk
RKRyan D Kaya
Ryan D Kaya
CWColin Waltz
Colin Waltz
EZEric Zimmerman
Eric Zimmerman
JJJoshua D. Johnston
Joshua D. Johnston
JAJay Lance Alberts
Jay Lance Alberts
Background/Objectives: Technological approaches for the objective, quantitative assessment of motor functions have the potential to improve the medical management of people with Parkinson’s disease (PwPD), offering more precise, data-driven insights to enhance diagnosis, monitoring, and treatment. Markerless motion capture (MMC) is a promising approach for the integration of biomechanical analysis into clinical practice. The aims of this project were to evaluate a commercially available MMC system, develop and validate a custom MMC data processing algorithm, and evaluate the effectiveness of the algorithm in discriminating fine motor performance between PwPD and healthy controls (HCs). Methods: A total of 58 PwPD and 25 HCs completed finger-tapping assessments, administered and recorded by a self-worn augmented reality headset. Fine motor performance was evaluated using the headset’s built-in hand tracking software (Native-MMC) and a custom algorithm (CART-MMC). Outcomes from each were compared against a gold-standard motion capture system (Traditional-MC) to determine the equivalence. Known-group validity was evaluated using CART-MMC. Results: A total of 82 trials were analyzed for equivalence against the Traditional-MC, and 152 trials were analyzed for known-group validity. The CART-MMC outcomes were statistically equivalent to Traditional-MC (within 5%) for tap count, frequency, amplitude, and opening velocity metrics. The Native-MMC did not meet equivalence with the Traditional-MC, deviating by an average of 24% across all outcomes. The CART-MMC captured significant differences between PwPD and HCs for tapping amplitude, amplitude variability, frequency variability, finger opening and closing velocities, and their respective variabilities, and normalized path length. Conclusions: The biomechanical data gathered using a commercially available augmented reality device and analyzed via a custom algorithm accurately characterize fine motor performance in PwPD.

18 August 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SJSumner Jones
Sumner Jones
CWColin Waltz
Colin Waltz
EZEric Zimmerman
Eric Zimmerman
MKMandy Miller Koop
Mandy Miller Koop
KHKarissa Hastilow
Karissa Hastilow
JAJay Lance Alberts
Jay Lance Alberts
Background: Stair ambulation is a complex motor task that presents a substantial fall risk for people with Parkinson’s disease (PwPD) who often have postural instability and gait difficulty (PIGD) and experience unpredictable freezing of gait (FOG) episodes. While dual-task (DT) interference during level walking is well-documented, its impact on stair ambulation, an everyday, high-risk activity, remains poorly understood. Objective: The aim of this study was to quantify the impact of dual tasking on patterns of motor control during stair ambulation using kinetic data from The Stair Ambulation and Functional Evaluation of Gait (Safe-Gait) system. Methods: Seventeen individuals with Parkinson’s disease (PD) completed three single-task (ST) and three dual-task (DT) trials on the Safe-Gait system, which sampled kinetic data via embedded force plates during stair ascent and descent. The force plate data were used to quantify step time, braking and propulsive impulses, and center of pressure (CoP) displacement and sway speed to assess DT effects on stair ambulation kinetics. Results: Dual-task conditions led to significant increases in step time (p < 0.001), braking impulse (p < 0.01), anteroposterior center of pressure (CoP) range (p < 0.05), and a decrease in mediolateral CoP speed (p < 0.01). Conclusions: Dual tasking during stair ambulation altered gait kinetics in PwPD, evidenced by slower, less stable movement patterns. These findings highlight the impact of cognitive motor DT interference on functional mobility and support the use of instrumented stair assessments to guide therapeutic care and fall risk interventions.

28 June 2025 in Sensors
Verified
Journal Article
Open access
PDF file
MKMandy Miller Koop
Mandy Miller Koop
ARAnson Rosenfeldt
Anson Rosenfeldt
KSKathryn Scelina
Kathryn Scelina
LSLogan Scelina
Logan Scelina
CWColin Waltz
Colin Waltz
JAJay Lance Alberts
Jay Lance Alberts
Freezing of gait (FOG) is a disabling symptom associated with Parkinson’s disease (PD). Its understanding and effective treatment is compromised due to the difficulty in reliably triggering FOG in clinical and laboratory environments. The Cleveland Clinic-Virtual Home Environment (CC-VHE) platform was developed to address the challenges of eliciting FOG by combining an omnidirectional treadmill with immersive virtual reality (VR) environments to induce FOG under physical, emotional, and cognitive triggers. Recent developments in deep brain stimulation devices that sense neural signals from the subthalamic nucleus in real time offer the potential to understand the underlying neural mechanism(s) of FOG. This manuscript presents the coupling of the CC-VHE technology, VR paradigms, and the experimental and analytical methods for recording and analyzing synchronous cortical, subcortical, and kinematic data as an approach to begin to understand the nuanced neural pathology associated with FOG. To evaluate the utility and feasibility of coupling VR and neural sensing technology, initial data from one participant are included.

13 February 2026 in Sensors
Verified
Journal Article
Open access
PDF file
ABAndrew Bazyk
Andrew Bazyk
CWColin Waltz
Colin Waltz
RKRyan D Kaya
Ryan D Kaya
EZEric Zimmerman
Eric Zimmerman
JJJoshua D. Johnston
Joshua D. Johnston
JAJay Lance Alberts
Jay Lance Alberts
Subjective, imprecise evaluation of lower extremity function hinders the effective treatment of gait impairments in Parkinson’s disease (PD). Markerless motion capture (MMC) offers opportunities for integrating objective biomechanical outcomes into clinical practice. However, validation of MMC biomechanical outcomes is necessary for clinical adoption of MMC technologies. This project evaluated the criterion validity of a custom MMC algorithm (CART-MMC) against gold-standard 3D motion capture (Traditional-MC) and its known-groups validity in differentiating PD from healthy controls (HC). Sixty-two individuals with PD and 29 HCs completed a stepping in place paradigm. The trials were recorded by an augmented reality headset with embedded RGB and depth cameras. The CART-MMC algorithm was used to reconstruct a 3D pose model and compute biomechanical measures of lower extremity performance. CART-MMC outcomes were statistically equivalent, within 5% of Traditional-MC, for measures of step count, cadence, duration, height, height asymmetry, and normalized path length. CART-MMC captured significant between-group differences in step height, height variability, height asymmetry, duration variability, and normalized path length. In conclusion, CART-MMC provides valid biomechanical outcomes that characterize important domains of PD lower extremity function. Validated biomechanical evaluation tools present opportunities for tracking subtle changes in disease progression, informing targeted therapy, and monitoring treatment efficacy.

26 June 2026 in Gait & Posture
Verified
Journal Article
Open access
CWColin Waltz
Colin Waltz
ARAnson B. Rosenfeldt
Anson B. Rosenfeldt
SJSumner Jones
Sumner Jones
EZEric Zimmerman
Eric Zimmerman
JGJohn Gardner
John Gardner
JAJay Lance Alberts
Jay Lance Alberts
The Stair Ambulation and Functional Evaluation of Gait (Safe-Gait) platform was developed as a comprehensive and objective assessment of functional mobility that combines stair ambulation, level-ground walking, and turning within a single assessment. This project aimed to determine the effects of antiparkinsonian medication and dual-tasking on overall time to completion and phase-specific temporal measures to objectively quantify mobility performance in people with PD. Thirty-two people with PD completed the Safe-Gait test under single-task (ST) and dual-task (DT) conditions while ON- and OFF-antiparkinsonian medication. Completion time was the primary outcome; secondary outcomes were completion times for the six Safe-Gait phases: gait initiation, stair ascent, level-ground walking (departure & return), turning, and stair descent. A linear mixed model was used to evaluate the effects of medication and task condition. No significant medication-by-task interaction was observed. However, main effects for task and medication were present. Completion time was 6.2% longer OFF-medication than ON-medication, with the smallest medication-related effect observed in the gait initiation phase (2%). Completion time was 13% longer under DT conditions than ST, with the largest DT interference (DTI) observed in the gait initiation phase (21%). While dopaminergic medication improved overall functional mobility, it did not mitigate DTI. Gait initiation showed minimal responsiveness to medication and the greatest DTI, highlighting its heightened sensitivity to combined motor and cognitive demands. These findings support the Safe-Gait platform as a sensitive, ecologically valid tool for rapidly quantifying multiple aspects of functional mobility in people with PD.